Elaspol


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 22.7%
Pneumonia 14.8%
Hypertension 10.2%
Acute Respiratory Distress Syndrome 8.0%
Interstitial Lung Disease 8.0%
Sedation 6.8%
Pyrexia 5.1%
Gastric Ulcer 3.4%
Prophylaxis 3.4%
Vomiting 2.8%
Pneumonia Aspiration 2.3%
Diarrhoea 1.7%
Disseminated Intravascular Coagulation 1.7%
Idiopathic Pulmonary Fibrosis 1.7%
Lung Disorder 1.7%
Asthma 1.1%
Cardiac Failure 1.1%
Chronic Obstructive Pulmonary Disease 1.1%
Fungal Infection 1.1%
Parenteral Nutrition 1.1%
Toxic Epidermal Necrolysis 40.0%
Transient Ischaemic Attack 11.4%
Hepatic Function Abnormal 8.6%
White Blood Cell Count Decreased 8.6%
Renal Disorder 5.7%
Systemic Inflammatory Response Syndrome 5.7%
Granulocytopenia 2.9%
Hyperbilirubinaemia 2.9%
Hypernatraemia 2.9%
Platelet Count Decreased 2.9%
Pyrexia 2.9%
Respiratory Failure 2.9%
Staphylococcal Infection 2.9%
Concomitant
Drug Use For Unknown Indication 20.3%
Prophylaxis 13.9%
Pneumonia 10.9%
Nutritional Support 5.2%
Pneumonia Aspiration 5.1%
Interstitial Lung Disease 4.8%
Multiple Myeloma 4.3%
Product Used For Unknown Indication 3.9%
Sedation 3.9%
Disseminated Intravascular Coagulation 3.6%
Idiopathic Pulmonary Fibrosis 3.3%
Sepsis 3.3%
Acute Respiratory Distress Syndrome 2.5%
Cancer Pain 2.4%
Constipation 2.4%
Shock 2.3%
Infection 2.2%
Colon Cancer 2.2%
Hypertension 1.9%
Cardiac Failure 1.8%
Renal Impairment 11.1%
Sepsis 11.1%
Toxic Epidermal Necrolysis 9.0%
Pneumonia 6.9%
Rhabdomyolysis 6.9%
White Blood Cell Count Decreased 6.9%
Renal Failure Acute 6.3%
Interstitial Lung Disease 5.6%
Pneumonia Aspiration 4.9%
Hepatic Function Abnormal 3.5%
Superinfection 3.5%
Acute Respiratory Distress Syndrome 2.8%
Cardiac Failure 2.8%
Death 2.8%
Insomnia 2.8%
Multi-organ Failure 2.8%
Pulmonary Embolism 2.8%
Renal Failure 2.8%
Ventricular Tachycardia 2.8%
Disseminated Intravascular Coagulation 2.1%

Drug Data